These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. Alvarez A; Opazo C; Alarcón R; Garrido J; Inestrosa NC J Mol Biol; 1997 Sep; 272(3):348-61. PubMed ID: 9325095 [TBL] [Abstract][Full Text] [Related]
24. Discovery and Biological Evaluation of New Selective Acetylcholinesterase Inhibitors with Anti-Aβ Aggregation Activity through Molecular Docking-Based Virtual Screening. Liu G; Jiao Y; Lin Y; Hao H; Dou Y; Yang J; Jiang CS; Chang P Chem Pharm Bull (Tokyo); 2020 Feb; 68(2):161-166. PubMed ID: 31813907 [TBL] [Abstract][Full Text] [Related]
25. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study. Sun Y; Qian Z; Wei G Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578 [TBL] [Abstract][Full Text] [Related]
26. Significant combination of Aβ aggregation inhibitory and neuroprotective properties in silico, in vitro and in vivo by bis(propyl)-cognitin, a multifunctional anti-Alzheimer's agent. Hu S; Xian Y; Fan Y; Mak S; Wang J; Tang J; Pang Y; Pi R; Tsim KW; Liu F; Lin Z; Han Y Eur J Pharmacol; 2020 Jun; 876():173065. PubMed ID: 32171792 [TBL] [Abstract][Full Text] [Related]
27. Design, Synthesis, Calculation and Biological Activity Studies Based on Privileged Coumarin Derivatives as Multifunctional Anti-AD Lead Compound. Wang H; Su M; Shi X; Li X; Zhang X; Yang A; Shen R Chem Biodivers; 2023 Jan; 20(1):e202200867. PubMed ID: 36461922 [TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological evaluation of novel deoxyvasicinone-indole as multi-target agents for Alzheimer's disease. Nerella A; Jeripothula M Bioorg Med Chem Lett; 2021 Oct; 49():128212. PubMed ID: 34153471 [TBL] [Abstract][Full Text] [Related]
29. Lanosterol Disrupts the Aggregation of Amyloid-β Peptides. Zhou H; Yang Z; Tian X; Chen L; Lee S; Huynh T; Ge C; Zhou R ACS Chem Neurosci; 2019 Sep; 10(9):4051-4060. PubMed ID: 31369236 [TBL] [Abstract][Full Text] [Related]
30. Insights into the Interaction Mechanism of Ligands with Aβ42 Based on Molecular Dynamics Simulations and Mechanics: Implications of Role of Common Binding Site in Drug Design for Alzheimer's Disease. Kundaikar HS; Degani MS Chem Biol Drug Des; 2015 Oct; 86(4):805-12. PubMed ID: 25763767 [TBL] [Abstract][Full Text] [Related]
31. Medicinal value of asiaticoside for Alzheimer's disease as assessed using single-molecule-detection fluorescence correlation spectroscopy, laser-scanning microscopy, transmission electron microscopy, and in silico docking. Hossain S; Hashimoto M; Katakura M; Al Mamun A; Shido O BMC Complement Altern Med; 2015 Apr; 15():118. PubMed ID: 25880304 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of flavone-8-acrylamide derivatives as potential multi-target-directed anti Alzheimer agents and investigation of binding mechanism with acetylcholinesterase. Shaik JB; Yeggoni DP; Kandrakonda YR; Penumala M; Zinka RB; Kotapati KV; Darla MM; Ampasala DR; Subramanyam R; Amooru DG Bioorg Chem; 2019 Jul; 88():102960. PubMed ID: 31102808 [TBL] [Abstract][Full Text] [Related]
33. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics. Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794 [TBL] [Abstract][Full Text] [Related]
35. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease. Manral A; Saini V; Meena P; Tiwari M Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018 [TBL] [Abstract][Full Text] [Related]
36. Islet Amyloid Polypeptide Promotes Amyloid-Beta Aggregation by Binding-Induced Helix-Unfolding of the Amyloidogenic Core. Ge X; Yang Y; Sun Y; Cao W; Ding F ACS Chem Neurosci; 2018 May; 9(5):967-975. PubMed ID: 29378116 [TBL] [Abstract][Full Text] [Related]
37. Acetylcholinesterase triggers the aggregation of PrP 106-126. Pera M; Román S; Ratia M; Camps P; Muñoz-Torrero D; Colombo L; Manzoni C; Salmona M; Badia A; Clos MV Biochem Biophys Res Commun; 2006 Jul; 346(1):89-94. PubMed ID: 16750169 [TBL] [Abstract][Full Text] [Related]
38. Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease. Shaik JB; Palaka BK; Penumala M; Eadlapalli S; Darla Mark M; Ampasala DR; Vadde R; Amooru Gangaiah D Chem Biol Drug Des; 2016 Jul; 88(1):43-53. PubMed ID: 26833890 [TBL] [Abstract][Full Text] [Related]
39. Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation. Zha GF; Zhang CP; Qin HL; Jantan I; Sher M; Amjad MW; Hussain MA; Hussain Z; Bukhari SN Bioorg Med Chem; 2016 May; 24(10):2352-9. PubMed ID: 27083471 [TBL] [Abstract][Full Text] [Related]
40. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents. Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]